FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

Lineage Cell Therapeutics, Inc.: capex

One fact, its scope and the complete path back to the official record.

Period: 2014-01-01 – 2014-06-30Status: supersededProvenance attached

Cite: FACTANKER, https://factanker.com/fact/22e55c63-848c-431c-8e12-1c53f6cf84e4

Reported value

$404.649k{"amount": 404649, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Entity
Lineage Cell Therapeutics, Inc.
Metric
capex
Period
2014-01-01 – 2014-06-30
Status
superseded
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001140361-14-031789 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T08:43:16.416080+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0000876343/capex/2014-06-30 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.